Dr. Mario Troisi is a clinician–scientist ophthalmologist currently serving at Salerno University Hospital, Italy, where he is actively involved in advanced clinical care, translational research, and surgical ophthalmology. He is a Fellow of the European Board of Ophthalmology (FEBO) and the principal investigator of numerous research studies, reflecting his strong commitment to academic excellence and clinical advancement.

His academic profile bridges clinical ophthalmology, corneal and ocular surface disease, glaucoma, cataract and refractive surgery, with growing leadership in systematic reviews, meta-research, and artificial intelligence applications in eye care.

Research Focus and Scientific Contributions

Dr. Troisi’s research portfolio encompasses:

• Cornea and ocular surface diseases

• Dry eye disease and systemic autoimmune conditions

• Glaucoma and cataract surgery outcomes

• Evidence synthesis (systematic reviews and Cochrane methodologies)

• Artificial intelligence and digital innovation in ophthalmology

He has authored 46 peer-reviewed scientific publications, including original articles, reviews, conference proceedings, and book chapters, demonstrating sustained scholarly productivity and international collaboration.

Books and Editorial Leadership

• Editor, Artificial Intelligence in Ophthalmology – Principles, Clinical Applications, and Future Directions, IntechOpen (2025)

• Author, Microvilli: An Essential Biomarker of the Ocular Surface (Monograph), Momento Medico (2025)

• Book Chapter, Quality-of-life impact in systemic Sjögren syndrome (2021)

These works highlight his role in shaping emerging scientific discourse, particularly at the intersection of technology and clinical ophthalmology.

Awards, Honors, and International Recognition

Dr. Troisi has received numerous prestigious national and international awards, including:

• Best Paper and Best Poster awards from ESCRS, EuCornea, SICSSO, EVER, SOC, and other major ophthalmic societies

• Competitive ESCRS, MDPI, and EVER travel grants and bursaries

• Lifetime Achievement in Medical Innovation and Eye Health, 14th World Leaders Summit, University of Oxford (2025)

• Cochrane Membership Award, Sigma Xi Full Membership, and Web of Science Academy Graduate & Mentor

• Recognition as Best Reviewer and Excellent Reviewer across multiple international journals

These distinctions reflect both scientific excellence and global peer recognition.

Academic Service and Peer-Review Excellence

Dr. Troisi is an active peer reviewer and mentor within the global scientific community, with formal recognition from:

• Web of Science

• Cochrane

• Multiple international ophthalmology journals

His work strengthens research integrity, transparency, and methodological rigor.

Eligibility for Nobel Research Award

Based on his sustained high-impact research output, international awards, editorial leadership, innovation in ophthalmology, and contributions to evidence-based medicine, Dr. Mario Troisi meets the eligibility criteria for major international scientific honors, including Nobel-level research distinction programs and scientific laurel awards that recognize transformative contributions to medical science.

His career trajectory demonstrates the originality, global influence, and long-term scientific relevance expected of candidates for the Nobel Research Award (Scientific Laurels category) and other elite international research recognitions.